![](/img/cover-not-exists.png)
P387 Persistence of antibodies to infliximab for more than two months strongly predicts loss of response to infliximab in inflammatory bowel diseases
Leclerc, M., Marotte, H., Paul, S., Del Tedesco, E., Gonzalo, P., Phelip, J.M., Peyrin Biroulet, L., Roblin, X.Volume:
8
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1016/S1873-9946(14)60507-9
Date:
February, 2014
File:
PDF, 66 KB
english, 2014